Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Publication Date Range:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 521 - 540 of 723 results

Meningococcal disease, All serogroups (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

03/28/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Meningococcal disease, All serogroups. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities repor ...

04/03/2026

Supporting Files

Title : Meningococcal disease, All serogroups (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 03/28/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254917 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Meningococcal disease, All serogroups (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026. 2026(12). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Meningococcal disease, All serogroups (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" 2026, no. 12 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Meningococcal disease, All serogroups (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" vol. 2026, no. 12, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Meningococcal disease, All serogroups. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-12-10150.pdf AN - cdc:254917 CY - Atlanta, GA IS - 12 KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Meningococcal Disease KW - Public Health Surveillance KW - Meningococcal Disease KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance LA - eng PY - 03/28/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Meningococcal disease, All serogroups (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254917 ER -
Malaria (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

03/28/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Malaria. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health ...

04/03/2026

Supporting Files

Title : Malaria (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 03/28/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254916 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Malaria (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026. 2026(12). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Malaria (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" 2026, no. 12 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Malaria (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" vol. 2026, no. 12, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Malaria. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-12-10130.pdf AN - cdc:254916 CY - Atlanta, GA IS - 12 KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Malaria KW - Public Health Surveillance KW - Malaria KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance LA - eng PY - 03/28/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Malaria (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254916 ER -
Hepatitis A, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

03/28/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Hepatitis A, Confirmed. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to ...

04/03/2026

Supporting Files

Title : Hepatitis A, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 03/28/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254915 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Hepatitis A, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026. 2026(12). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Hepatitis A, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" 2026, no. 12 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Hepatitis A, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" vol. 2026, no. 12, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Hepatitis A, Confirmed. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-12-10110.pdf AN - cdc:254915 CY - Atlanta, GA IS - 12 KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Hepatitis A KW - Public Health Surveillance KW - Hepatitis A KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance LA - eng PY - 03/28/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Hepatitis A, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254915 ER -
Hepatitis B, perinatal, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

03/28/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Hepatitis B, perinatal, Confirmed. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report co ...

04/03/2026

Supporting Files

Title : Hepatitis B, perinatal, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 03/28/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254914 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Hepatitis B, perinatal, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026. 2026(12). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Hepatitis B, perinatal, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" 2026, no. 12 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Hepatitis B, perinatal, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" vol. 2026, no. 12, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Hepatitis B, perinatal, Confirmed. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-12-10104.pdf AN - cdc:254914 CY - Atlanta, GA IS - 12 KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Hepatitis B, Chronic KW - Public Health Surveillance KW - Hepatitis B, Chronic KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance LA - eng PY - 03/28/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Hepatitis B, perinatal, Confirmed (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254914 ER -
Arboviral diseases, Chikungunya virus disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

03/28/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Arboviral diseases, Chikungunya virus disease. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entiti ...

04/03/2026

Supporting Files

Title : Arboviral diseases, Chikungunya virus disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 03/28/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254913 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Arboviral diseases, Chikungunya virus disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026. 2026(12). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Arboviral diseases, Chikungunya virus disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" 2026, no. 12 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Arboviral diseases, Chikungunya virus disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" vol. 2026, no. 12, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Arboviral diseases, Chikungunya virus disease. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-12-10073.pdf AN - cdc:254913 CY - Atlanta, GA IS - 12 KW - Chikungunya virus KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance KW - Chikungunya virus KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance LA - eng PY - 03/28/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Arboviral diseases, Chikungunya virus disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254913 ER -
Varicella disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

03/28/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Varicella disease. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to publ ...

04/03/2026

Supporting Files

Title : Varicella disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 03/28/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254912 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Varicella disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026. 2026(12). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Varicella disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" 2026, no. 12 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Varicella disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" vol. 2026, no. 12, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Varicella disease. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-12-10030.pdf AN - cdc:254912 CY - Atlanta, GA IS - 12 KW - Chickenpox / prevention & control KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance KW - Varicella disease KW - Chickenpox / prevention & control KW - Varicella disease KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance LA - eng PY - 03/28/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Varicella disease (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254912 ER -
Brucellosis (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

03/28/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Brucellosis. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public hea ...

04/03/2026

Supporting Files

Title : Brucellosis (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 03/28/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254911 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Brucellosis (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026. 2026(12). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Brucellosis (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" 2026, no. 12 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Brucellosis (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026" vol. 2026, no. 12, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Brucellosis. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-12-10020.pdf AN - cdc:254911 CY - Atlanta, GA IS - 12 KW - Brucellosis KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance KW - Brucellosis KW - Communicable Diseases/epidemiology KW - Data Collection KW - Disease Notification KW - Public Health Surveillance LA - eng PY - 03/28/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Brucellosis (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 28, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254911 ER -
Cognitive Interview Findings for Rapid Surveys System Round 7 Question Evaluation

Willson, Stephanie ;

Ryan,Valerie

4/1/2026 | Q-Bank - Question Evaluation Reports

This report summarize key findings and detailed results from a cognitive evaluation of Rapid Surveys System (RSS) Round 7 questionnaire covering topics such as Lyme disease prevention, complementary and integrative health, GLP-1 medication access, lung cancer screening, and fertility and reproductive health services

04/03/2026

Title : Cognitive Interview Findings for Rapid Surveys System Round 7 Question Evaluation Personal Author(s) : Willson, Stephanie;Ryan,Valerie; Corporate Authors(s) : National Center for Health Statistics (U.S.) Published Date : 4/1/2026 Pages in Document : 97 pdf pages Series : Q-Bank - Question Evaluation Reports URL : https://stacks.cdc.gov/view/cdc/254910 Willson, Stephanie and Ryan,Valerie (2026). Cognitive Interview Findings for Rapid Surveys System Round 7 Question Evaluation. Willson, Stephanie and Ryan,Valerie "Cognitive Interview Findings for Rapid Surveys System Round 7 Question Evaluation" (2026) Willson, Stephanie and Ryan,Valerie "Cognitive Interview Findings for Rapid Surveys System Round 7 Question Evaluation" , 2026 Export RIS Citation Information. TY - Report AU - Willson, Stephanie AU - Ryan,Valerie A2 - National Center for Health Statistics (U.S.) AB - This report summarize key findings and detailed results from a cognitive evaluation of Rapid Surveys System (RSS) Round 7 questionnaire covering topics such as Lyme disease prevention, complementary and integrative health, GLP-1 medication access, lung cancer screening, and fertility and reproductive health services AN - cdc:254910 CY - Hyattsville, MD KW - Data Collection KW - Drug Accessibility KW - GLP-1 KW - Glucagon-Like Peptide 1 Receptor Agonists KW - Health Surveys KW - Interviews as Topic KW - Surveys and Questionnaires KW - Lyme disease prevention KW - complementary and integrative health KW - GLP-1 medication access KW - lung cancer screening KW - fertility KW - reproductive health services KW - Interviews as Topic KW - Surveys and Questionnaires KW - Health Surveys KW - Data Collection KW - Glucagon-Like Peptide 1 Receptor Agonists KW - Drug Accessibility KW - GLP-1 LA - eng PY - 4/1/2026 T3 - Q-Bank - Question Evaluation Reports TI - Cognitive Interview Findings for Rapid Surveys System Round 7 Question Evaluation UR - https://stacks.cdc.gov/view/cdc/254910 ER -
Oropouche, non-congenital (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

02/21/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Oropouche, non-congenital. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions ...

04/02/2026

Supporting Files

Title : Oropouche, non-congenital (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 02/21/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254909 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Oropouche, non-congenital (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026. 2026(7). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Oropouche, non-congenital (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026" 2026, no. 7 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Oropouche, non-congenital (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026" vol. 2026, no. 7, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Oropouche, non-congenital. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-7-50290.pdf AN - cdc:254909 CY - Atlanta, GA IS - 7 KW - Oropouche, non-congenital KW - Oropouche, non-congenital LA - eng PY - 02/21/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Oropouche, non-congenital (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254909 ER -
Oropouche, non-congenital (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

02/14/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Oropouche, non-congenital. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions ...

04/02/2026

Supporting Files

Title : Oropouche, non-congenital (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 02/14/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254908 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Oropouche, non-congenital (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026. 2026(6). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Oropouche, non-congenital (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026" 2026, no. 6 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Oropouche, non-congenital (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026" vol. 2026, no. 6, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Oropouche, non-congenital. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-6-50290.pdf AN - cdc:254908 CY - Atlanta, GA IS - 6 KW - Oropouche, non-congenital KW - Oropouche, non-congenital LA - eng PY - 02/14/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Oropouche, non-congenital (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254908 ER -
Oropouche, non-congenital (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

02/07/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Oropouche, non-congenital. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions ...

04/02/2026

Supporting Files

Title : Oropouche, non-congenital (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 02/07/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254907 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). Oropouche, non-congenital (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026. 2026(5). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Oropouche, non-congenital (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026" 2026, no. 5 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "Oropouche, non-congenital (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026" vol. 2026, no. 5, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: Oropouche, non-congenital. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-5-50290.pdf AN - cdc:254907 CY - Atlanta, GA IS - 5 KW - Oropouche, non-congenital KW - Oropouche, non-congenital LA - eng PY - 02/07/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - Oropouche, non-congenital (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254907 ER -
COVID-19-associated pediatric mortality (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

02/21/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: COVID-19-associated pediatric mortality. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities rep ...

04/02/2026

Supporting Files

Title : COVID-19-associated pediatric mortality (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 02/21/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254906 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). COVID-19-associated pediatric mortality (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026. 2026(7). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "COVID-19-associated pediatric mortality (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026" 2026, no. 7 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "COVID-19-associated pediatric mortality (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026" vol. 2026, no. 7, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: COVID-19-associated pediatric mortality. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-7-11069.pdf AN - cdc:254906 CY - Atlanta, GA IS - 7 KW - COVID-19-associated pediatric mortality KW - COVID-19-associated pediatric mortality LA - eng PY - 02/21/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - COVID-19-associated pediatric mortality (Week 7) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 21, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254906 ER -
COVID-19-associated pediatric mortality (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

02/14/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: COVID-19-associated pediatric mortality. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities rep ...

04/02/2026

Supporting Files

Title : COVID-19-associated pediatric mortality (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 02/14/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254905 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). COVID-19-associated pediatric mortality (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026. 2026(6). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "COVID-19-associated pediatric mortality (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026" 2026, no. 6 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "COVID-19-associated pediatric mortality (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026" vol. 2026, no. 6, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: COVID-19-associated pediatric mortality. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-6-11069.pdf AN - cdc:254905 CY - Atlanta, GA IS - 6 KW - COVID-19-associated pediatric mortality KW - COVID-19-associated pediatric mortality LA - eng PY - 02/14/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - COVID-19-associated pediatric mortality (Week 6) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 14, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254905 ER -
COVID-19-associated pediatric mortality (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026

Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.

02/07/2026 | National Notifiable Diseases: Infectious Weekly Tables

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: COVID-19-associated pediatric mortality. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities rep ...

04/02/2026

Supporting Files

Title : COVID-19-associated pediatric mortality (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. Published Date : 02/07/2026 Series : National Notifiable Diseases: Infectious Weekly Tables URL : https://stacks.cdc.gov/view/cdc/254904 Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. (2026). COVID-19-associated pediatric mortality (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026. 2026(5). Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "COVID-19-associated pediatric mortality (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026" 2026, no. 5 (2026) Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. "COVID-19-associated pediatric mortality (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026" vol. 2026, no. 5, 2026 Export RIS Citation Information. TY - Weekly Tables A2 - Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System. AB - This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering: COVID-19-associated pediatric mortality. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/ AB - 2026-5-11069.pdf AN - cdc:254904 CY - Atlanta, GA IS - 5 KW - COVID-19-associated pediatric mortality KW - COVID-19-associated pediatric mortality LA - eng PY - 02/07/2026 T3 - National Notifiable Diseases: Infectious Weekly Tables TI - COVID-19-associated pediatric mortality (Week 5) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 07, 2026 VL - 2026 UR - https://stacks.cdc.gov/view/cdc/254904 ER -
U.S. CDC Rwanda 2024 Annual Report

Center for Global Health (U.S.)

2024

Annual report of the U.S. Centers for Disease Control and Prevention (CDC) Rwanda program highlighting its 2024 public health activities and achievements. The report focuses on efforts to combat HIV and tuberculosis, strengthen public health systems, support outbreak preparedness and response, and advance global health security through collaboratio ...

04/02/2026

Title : U.S. CDC Rwanda 2024 Annual Report Corporate Authors(s) : Center for Global Health (U.S.) Published Date : 2024 Pages in Document : 32 pdf pages URL : https://stacks.cdc.gov/view/cdc/254903 Center for Global Health (U.S.) (2024). U.S. CDC Rwanda 2024 Annual Report. Center for Global Health (U.S.) "U.S. CDC Rwanda 2024 Annual Report" (2024) Center for Global Health (U.S.) "U.S. CDC Rwanda 2024 Annual Report" , 2024 Export RIS Citation Information. TY - Pamphlet (or booklet) A2 - Center for Global Health (U.S.) AB - Annual report of the U.S. Centers for Disease Control and Prevention (CDC) Rwanda program highlighting its 2024 public health activities and achievements. The report focuses on efforts to combat HIV and tuberculosis, strengthen public health systems, support outbreak preparedness and response, and advance global health security through collaboration with the Rwanda Ministry of Health and partners. AB - CDC Rwanda was established in 2002 with support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Since then, CDC has supported the Rwanda Ministry of Health in comprehensive activities to combat HIV, strengthen public health systems and ensure global health security. This annual report showcases the U.S. CDC's substantial public health contributions in 2024. AB - Annual report highlighting CDC activities and public health contributions in Rwanda AB - Focus on HIV/AIDS programs, tuberculosis control, outbreak response, and health system strengthening AN - cdc:254903 CY - Atlanta, GA KW - Communicable Disease ControlRwanda KW - Disease Outbreaks/prevention & control KW - Global Health KW - HIV Infections KW - Health Policy KW - Health Programs, National KW - International Cooperation KW - Program Evaluation KW - Tuberculosis KW - United States KW - HIV Infections KW - Tuberculosis KW - Global Health KW - Communicable Disease ControlRwanda KW - Health Programs, National KW - Disease Outbreaks/prevention & control KW - Health Policy KW - Program Evaluation KW - International Cooperation KW - United States LA - eng PY - 2024 TI - U.S. CDC Rwanda 2024 Annual Report UR - https://stacks.cdc.gov/view/cdc/254903 ER -
Guidance for Implementing National Security Presidential Memorandum 33 (NSPM-33) on National Security Strategy for United States Government-Supported Research and Development

Lander, Eric S.

2022/01/01

National Security Presidential Memorandum 33 (NSPM-33) established national security policy for U.S. Government-supported R&D. The purpose of NSPM-33 is to strengthen protections of U.S. Government-supported R&D against foreign government interference and misappropriation, while maintaining an open environment to foster research discoveries and inn ...

04/01/2026

Title : Guidance for Implementing National Security Presidential Memorandum 33 (NSPM-33) on National Security Strategy for United States Government-Supported Research and Development Personal Author(s) : Lander, Eric S. Corporate Authors(s) : United States. White House. Office of Science and Technology Policy (OSTP). Subcommittee on Research Security. Joint Committee on the Research Environment Published Date : 2022/01/01 Pages in Document : 34 pdf pages URL : https://stacks.cdc.gov/view/cdc/254902 Lander, Eric S. (2022). Guidance for Implementing National Security Presidential Memorandum 33 (NSPM-33) on National Security Strategy for United States Government-Supported Research and Development. Lander, Eric S. "Guidance for Implementing National Security Presidential Memorandum 33 (NSPM-33) on National Security Strategy for United States Government-Supported Research and Development" (2022) Lander, Eric S. "Guidance for Implementing National Security Presidential Memorandum 33 (NSPM-33) on National Security Strategy for United States Government-Supported Research and Development" , 2022 Export RIS Citation Information. TY - Guidance AU - Lander, Eric S. A2 - United States. White House. Office of Science and Technology Policy (OSTP). Subcommittee on Research Security. Joint Committee on the Research Environment AB - National Security Presidential Memorandum 33 (NSPM-33) established national security policy for U.S. Government-supported R&D. The purpose of NSPM-33 is to strengthen protections of U.S. Government-supported R&D against foreign government interference and misappropriation, while maintaining an open environment to foster research discoveries and innovation that benefit the United States and the world. As Federal departments and agencies (“agencies”) work to implement NSPM-33, it is critical that they do so in a consistent, coordinated manner that preserves the open and collaborative nature of the U.S. research enterprise, while providing strong and effective measures to protect research security and reinforce adherence to research responsibilities, transparency, and equity. The purpose of this document is to provide guidance to Federal departments and agencies regarding their implementation of NSPM-33. The guidance does not create or confer any rights for or on any person or entity and does not operate to bind any department or agency of the U.S. Government or the public. It includes general guidance that agencies should apply across their implementation efforts, followed by more detailed guidance in five key areas addressed in NSPM-33: 1. Disclosure Requirements and Standardization; 2. Digital Persistent Identifiers; 3. Consequences for Violation of Disclosure Requirements; 4. Information Sharing; and, 5. Research Security Programs. Consistent with NSPM-33, this guidance includes a significant focus on upholding transparency through clearly-articulated requirements and processes for appropriate disclosure of information related to potential conflicts of interest and conflicts of commitment. Effective implementation of research security policy will make it more difficult for individuals to conceal materially important support, obligations, conflicts of interest, and/or relationships that, when concealed, could lead to Federal research agencies (“research agencies”) making inadequately informed funding decisions. Effective implementation will also make it easier for R&D award recipients and research agencies to identify and address noncompliance in a timely and fair manner. AN - cdc:254902 KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports KW - Data Files KW - Data Sharing KW - Digital Object Identifier KW - DOI KW - Findable, Accessible, Interoperable, And Reusable KW - FAIR KW - Government Funding KW - Persistent Identifiers KW - PIDs KW - Public Access KW - Repositories KW - Research and Development KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports LA - eng PB - United States. Office of Science and Technology Policy PY - 2022/01/01 TI - Guidance for Implementing National Security Presidential Memorandum 33 (NSPM-33) on National Security Strategy for United States Government-Supported Research and Development UR - https://stacks.cdc.gov/view/cdc/254902 ER -
Memorandum for the Heads of Executive Departments and Agencies: Open Data Policy--Managing Information as an Asset

Burwell, Sylvia M. ;

VanRoekel, Steven

2013/05/09

Information is a valuable national resource and a strategic asset to the Federal Government, its partners, and the public. In order to ensure that the Federal Government is taking full advantage of its information resources, executive departments and agencies (hereafter referred to as "agencies") must manage information as an asset throughout its l ...

04/01/2026

Title : Memorandum for the Heads of Executive Departments and Agencies: Open Data Policy--Managing Information as an Asset Personal Author(s) : Burwell, Sylvia M.;VanRoekel, Steven;Park, Todd;Mancini, Dominic J.; Corporate Authors(s) : United States. Office of Management and Budget (OMB) Published Date : 2013/05/09 Pages in Document : 12 pdf pages URL : https://stacks.cdc.gov/view/cdc/254901 Burwell, Sylvia M. et al. (2013). Memorandum for the Heads of Executive Departments and Agencies: Open Data Policy--Managing Information as an Asset. Burwell, Sylvia M. et al. "Memorandum for the Heads of Executive Departments and Agencies: Open Data Policy--Managing Information as an Asset" (2013) Burwell, Sylvia M. et al. "Memorandum for the Heads of Executive Departments and Agencies: Open Data Policy--Managing Information as an Asset" , 2013 Export RIS Citation Information. TY - Memorandum AU - Burwell, Sylvia M. AU - VanRoekel, Steven AU - Park, Todd AU - Mancini, Dominic J. A2 - United States. Office of Management and Budget (OMB) AB - Information is a valuable national resource and a strategic asset to the Federal Government, its partners, and the public. In order to ensure that the Federal Government is taking full advantage of its information resources, executive departments and agencies (hereafter referred to as "agencies") must manage information as an asset throughout its life cycle to promote openness and interoperability, and properly safeguard systems and information. Managing government information as an asset will increase operational efficiencies, reduce costs, improve services, support mission needs, safeguard personal information, and increase public access to valuable government information. AN - cdc:254901 KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports KW - Data Files KW - Data Sharing KW - Digital Object Identifier KW - DOI KW - Findable, Accessible, Interoperable, And Reusable KW - FAIR KW - Government Funding KW - Persistent Identifiers KW - PIDs KW - Public Access KW - Repositories KW - Research and Development KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports LA - eng PB - United States. Office of Management and Budget (OMB) PY - 2013/05/09 TI - Memorandum for the Heads of Executive Departments and Agencies: Open Data Policy--Managing Information as an Asset UR - https://stacks.cdc.gov/view/cdc/254901 ER -
Memorandum for the Heads of Executive Departments and Agencies: Increasing Access to the Results of Federally Funded Scientific Research

Holdren, John P.

2013/02/22

This memorandum, issued on February 22, 2013 by the White House Office of Science and Technology Policy (OSTP) and directed to the heads of executive departments and agencies, calls for all federal agencies that are engaged in research and development to outline plans to provide public access to all results of scientific projects that are receiving ...

04/01/2026

Title : Memorandum for the Heads of Executive Departments and Agencies: Increasing Access to the Results of Federally Funded Scientific Research Personal Author(s) : Holdren, John P. Corporate Authors(s) : United States. White House. Office of Science and Technology Policy (OSTP) Published Date : 2013/02/22 Pages in Document : 6 pdf pages DOI : https://doi.org/10.21949/1528360 Holdren, John P. (2013). Memorandum for the Heads of Executive Departments and Agencies: Increasing Access to the Results of Federally Funded Scientific Research. https://doi.org/10.21949/1528360 Holdren, John P. "Memorandum for the Heads of Executive Departments and Agencies: Increasing Access to the Results of Federally Funded Scientific Research" (2013), https://doi.org/10.21949/1528360 Holdren, John P. "Memorandum for the Heads of Executive Departments and Agencies: Increasing Access to the Results of Federally Funded Scientific Research" , 2013, https://doi.org/10.21949/1528360 Export RIS Citation Information. TY - Memorandum AU - Holdren, John P. A2 - United States. White House. Office of Science and Technology Policy (OSTP) AB - This memorandum, issued on February 22, 2013 by the White House Office of Science and Technology Policy (OSTP) and directed to the heads of executive departments and agencies, calls for all federal agencies that are engaged in research and development to outline plans to provide public access to all results of scientific projects that are receiving federal funds. These plans were to be submitted to OSTP for review within six months of the publication of this memorandum. Plans must contain strategies addressing the following concerns: fostering public-private partnerships with scientific journals; improving access to digital data; optimizing archival and search features; plans for notifying federally funded researchers of their obligations; measurement and potential enforcement of compliance; identification of resources for implementation of the plan; and identification of circumstances that may exempt agency participation. OSTP further outlines specific objectives in increasing access to scientific publications as well as scientific data. Regarding scientific publications, OSTP requests that agencies ensure that the public can access final manuscripts in digital form, following a 12-month publication embargo as a guideline. OSTP also asks agencies to facilitate public search and analysis of peer-reviewed scholarly work and to ensure public access to publications’ metadata. In addition, agencies must encourage public-private collaboration, maintain accurate attribution to original authors, and provide archival solutions to storing metadata and publications that are publicly accessible. With respect to scientific data, OSTP requires that agencies maximize free public access to digitally formatted data created with federal funds, while protecting privacy and proprietary information. This involves requesting that grant recipients outline data management plans and detail any reasons why their data cannot be made publicly accessible. OSTP also requests that agencies allow for the inclusion of appropriate costs associated with data management and access in Federal grant proposals. AN - cdc:254900 DO - https://doi.org/10.21949/1528360 KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports KW - Data Files KW - Data Sharing KW - Digital Object Identifier KW - DOI KW - Findable, Accessible, Interoperable, And Reusable KW - FAIR KW - Government Funding KW - Persistent Identifiers KW - PIDs KW - Public Access KW - Repositories KW - Research and Development KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports LA - eng PB - United States. Office of Science and Technology Policy PY - 2013/02/22 TI - Memorandum for the Heads of Executive Departments and Agencies: Increasing Access to the Results of Federally Funded Scientific Research UR - https://stacks.cdc.gov/view/cdc/254900 ER -
Memorandum for the Heads of Executive Departments and Agencies: Ensuring Free, Immediate, and Equitable Access to Federally Funded Research

Nelson, Alondra

2022/08/25

This memorandum provides policy guidance to federal agencies with research and development expenditures on updating their public access policies. In accordance with this memorandum, OSTP recommends that federal agencies, to the extent consistent with applicable law: 1. Update their public access policies as soon as possible, and no later than Decem ...

04/01/2026

Title : Memorandum for the Heads of Executive Departments and Agencies: Ensuring Free, Immediate, and Equitable Access to Federally Funded Research Personal Author(s) : Nelson, Alondra Corporate Authors(s) : United States. White House. Office of Science and Technology Policy (OSTP) Published Date : 2022/08/25 Pages in Document : 8 pdf pages DOI : https://doi.org/10.21949/1528361 Nelson, Alondra (2022). Memorandum for the Heads of Executive Departments and Agencies: Ensuring Free, Immediate, and Equitable Access to Federally Funded Research. https://doi.org/10.21949/1528361 Nelson, Alondra "Memorandum for the Heads of Executive Departments and Agencies: Ensuring Free, Immediate, and Equitable Access to Federally Funded Research" (2022), https://doi.org/10.21949/1528361 Nelson, Alondra "Memorandum for the Heads of Executive Departments and Agencies: Ensuring Free, Immediate, and Equitable Access to Federally Funded Research" , 2022, https://doi.org/10.21949/1528361 Export RIS Citation Information. TY - Memorandum AU - Nelson, Alondra A2 - United States. White House. Office of Science and Technology Policy (OSTP) AB - This memorandum provides policy guidance to federal agencies with research and development expenditures on updating their public access policies. In accordance with this memorandum, OSTP recommends that federal agencies, to the extent consistent with applicable law: 1. Update their public access policies as soon as possible, and no later than December 31st, 2025, to make publications and their supporting data resulting from federally funded research publicly accessible without an embargo on their free and public release; 2. Establish transparent procedures that ensure scientific and research integrity is maintained in public access policies; and, 3. Coordinate with OSTP to ensure equitable delivery of federally funded research results and data. AN - cdc:254899 DO - https://doi.org/10.21949/1528361 KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports KW - Data Files KW - Data Sharing KW - Digital Object Identifier KW - DOI KW - Equitable Access KW - Findable, Accessible, Interoperable, And Reusable KW - FAIR KW - Government Funding KW - Persistent Identifiers KW - PIDs KW - Public Access KW - ORCID KW - Repositories KW - Research and Development KW - Access KW - Best Practices KW - Compliance KW - Contract Administration KW - Data Curation KW - Data Files KW - Data Management KW - Data Management Plans KW - Data Sharing KW - Government Funding KW - Information Dissemination KW - Information Management KW - Laws And Legislation KW - Policy KW - Policy, Legislation And Regulation KW - Public Access KW - Research KW - Research Management KW - Research Projects KW - Research Reports LA - eng PB - United States. Office of Science and Technology Policy PY - 2022/08/25 TI - Memorandum for the Heads of Executive Departments and Agencies: Ensuring Free, Immediate, and Equitable Access to Federally Funded Research UR - https://stacks.cdc.gov/view/cdc/254899 ER -
Morbidity and Mortality Weekly Report (MMWR) / Vol. 75/ No. 13, April 9, 2026

April 9, 2026 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

Epidemiological notes on specified notifiable diseases in the United States. This issue includes chocolate, agaricales, and poisoning.

03/31/2026

Supporting Files

Title : Morbidity and Mortality Weekly Report (MMWR) / Vol. 75/ No. 13, April 9, 2026 Published Date : April 9, 2026 Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR), 2026; v. 75, no.13 URL : https://stacks.cdc.gov/view/cdc/254898 Journal Title : Morbidity and Mortality Weekly Report (MMWR) "Morbidity and Mortality Weekly" (2026). 75(13). "Morbidity and Mortality Weekly Report (MMWR) / Vol. 75/ No. 13, April 9, 2026" 75, no. 13 (2026) "Morbidity and Mortality Weekly Report (MMWR) / Vol. 75/ No. 13, April 9, 2026" vol. 75, no. 13, 2026 Export RIS Citation Information. TY - Journal Issue AB - Epidemiological notes on specified notifiable diseases in the United States. This issue includes chocolate, agaricales, and poisoning. AN - cdc:254898 CY - gau IS - 13 J2 - Morbidity and Mortality Weekly Report (MMWR) KW - Agaricales KW - Chocolate KW - Communicable Diseases / epidemiology KW - Disease Notification KW - Mortality KW - Poisoning KW - Communicable Diseases / epidemiology KW - Disease Notification KW - Mortality KW - Chocolate KW - Agaricales KW - Poisoning LA - eng PY - April 9, 2026 T2 - Morbidity and Mortality Weekly Report (MMWR) T2 - Morbidity and Mortality Weekly Report (MMWR), 2026; v. 75, no.13 T3 - Weekly Report: Morbidity and Mortality Weekly Report (MMWR) TI - Morbidity and Mortality Weekly Report (MMWR) / Vol. 75/ No. 13, April 9, 2026 VL - 75 UR - https://stacks.cdc.gov/view/cdc/254898 ER -

Previous Page Previous

521 - 540 / 723

Next Page Next